Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
04 2021
Historique:
received: 28 01 2020
accepted: 13 01 2021
pubmed: 17 2 2021
medline: 24 4 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Oxytocin (OT) orchestrates social and emotional behaviors through modulation of neural circuits. In the central amygdala, the release of OT modulates inhibitory circuits and, thereby, suppresses fear responses and decreases anxiety levels. Using astrocyte-specific gain and loss of function and pharmacological approaches, we demonstrate that a morphologically distinct subpopulation of astrocytes expresses OT receptors and mediates anxiolytic and positive reinforcement effects of OT in the central amygdala of mice and rats. The involvement of astrocytes in OT signaling challenges the long-held dogma that OT acts exclusively on neurons and highlights astrocytes as essential components for modulation of emotional states under normal and chronic pain conditions.

Identifiants

pubmed: 33589833
doi: 10.1038/s41593-021-00800-0
pii: 10.1038/s41593-021-00800-0
doi:

Substances chimiques

Receptors, Oxytocin 0
Oxytocin 50-56-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-541

Subventions

Organisme : Intramural NIH HHS
ID : ZIA MH002498
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS094640
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL090948
Pays : United States

Références

Lee, H.-J., Macbeth, A. H., Pagani, J. H. & Young, W. S. Oxytocin: the great facilitator of life. Prog. Neurobiol. 88, 127–151 (2009).
pubmed: 19482229 pmcid: 2689929
Knobloch, H. S. et al. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73, 553–566 (2012).
pubmed: 22325206 doi: 10.1016/j.neuron.2011.11.030
Chini, B., Verhage, M. & Grinevich, V. The action radius of oxytocin release in the mammalian CNS: from single vesicles to behavior. Trends Pharmacol. Sci. 38, 982–991 (2017).
pubmed: 28899620 doi: 10.1016/j.tips.2017.08.005
Mitre, M. et al. A distributed network for social cognition enriched for oxytocin receptors. J. Neurosci. 36, 2517–2535 (2016).
pubmed: 26911697 pmcid: 4764667 doi: 10.1523/JNEUROSCI.2409-15.2016
Yoshida, M. et al. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J. Neurosci. 29, 2259–2271 (2009).
pubmed: 19228979 pmcid: 6666325 doi: 10.1523/JNEUROSCI.5593-08.2009
Theodosis, D. T. Oxytocin-secreting neurons: a physiological model of morphological neuronal and glial plasticity in the adult hypothalamus. Front. Neuroendocrinol. 23, 101–135 (2002).
pubmed: 11906204 doi: 10.1006/frne.2001.0226
Pacholko, A. G., Wotton, C. A. & Bekar, L. K. Astrocytes—the ultimate effectors of long-range neuromodulatory networks? Front. Cell. Neurosci. 14, 1–12 (2020).
doi: 10.3389/fncel.2020.581075
Huber, D., Veinante, P. & Stoop, R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308, 245–248 (2005).
pubmed: 15821089 doi: 10.1126/science.1105636
Viviani, D. et al. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 333, 104–107 (2011).
pubmed: 21719680 doi: 10.1126/science.1201043
Han, R. T. et al. Long-term isolation elicits depression and anxiety-related behaviors by reducing oxytocin-induced GABAergic transmission in central amygdala. Front. Mol. Neurosci. 11, 246 (2018).
pubmed: 30158853 pmcid: 6104450 doi: 10.3389/fnmol.2018.00246
Neugebauer, V., Li, W., Bird, G. C. & Han, J. S. The amygdala and persistent pain. Neuroscientist 10, 221–234 (2004).
pubmed: 15155061 doi: 10.1177/1073858403261077
Tye, K. M. et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471, 358–362 (2011).
pubmed: 21389985 pmcid: 3154022 doi: 10.1038/nature09820
Ji, R.-R., Donnelly, C. R. & Nedergaard, M. Astrocytes in chronic pain and itch. Nat. Rev. Neurosci. 20, 667–685 (2019).
pubmed: 31537912 pmcid: 6874831 doi: 10.1038/s41583-019-0218-1
Poisbeau, P., Grinevich, V. & Charlet, A. Oxytocin signaling in pain: cellular, circuit, system, and behavioral levels. Curr. Top. Behav. Neurosci. 35, 193–211 (2018).
Martin-Fernandez, M. et al. Synapse-specific astrocyte gating of amygdala-related behavior. Nat. Neurosci. 20, 1540–1548 (2017).
pubmed: 28945222 pmcid: 5903286 doi: 10.1038/nn.4649
Althammer, F. et al. Three-dimensional morphometric analysis reveals time-dependent structural changes in microglia and astrocytes in the central amygdala and hypothalamic paraventricular nucleus of heart failure rats. J. Neuroinflammation 17, 221 (2020).
pubmed: 32703230 pmcid: 7379770 doi: 10.1186/s12974-020-01892-4
Yizhar, O. et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171–178 (2011).
pubmed: 21796121 pmcid: 4155501 doi: 10.1038/nature10360
Lee, H. J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G. & Young, W. S. A conditional knockout mouse line of the oxytocin receptor. Endocrinology 149, 3256–3263 (2008).
pubmed: 18356275 pmcid: 2453083 doi: 10.1210/en.2007-1710
Wallraff, A. et al. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J. Neurosci. 26, 5438–5447 (2006).
pubmed: 16707796 pmcid: 6675300 doi: 10.1523/JNEUROSCI.0037-06.2006
Papouin, T., Dunphy, J. M., Tolman, M., Dineley, K. T. & Haydon, P. G. Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness. Neuron 94, 840–854 (2017).
pubmed: 28479102 pmcid: 5484087 doi: 10.1016/j.neuron.2017.04.021
Robin, L. M. et al. Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory. Neuron 98, 935–944 (2018).
pubmed: 29779943 doi: 10.1016/j.neuron.2018.04.034
Corkrum, M., Rothwell, P. E., Thomas, M. J., Kofuji, P. & Araque, A. Opioid-mediated astrocyte-neuron signaling in the nucleus accumbens. Cells 8, 586 (2019).
pmcid: 6628279 doi: 10.3390/cells8060586
Li, Y. et al. Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. Nat. Commun. 4, 1760 (2013).
pubmed: 23612301 doi: 10.1038/ncomms2779
Decosterd, I. & Woolf, C. J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87, 149–158 (2000).
pubmed: 10924808 doi: 10.1016/S0304-3959(00)00276-1
Thompson, J. M. & Neugebauer, V. Amygdala plasticity and pain. Pain Res. Manag. 2017, 8296501 (2017).
pubmed: 29302197 pmcid: 5742506 doi: 10.1155/2017/8296501
Sieberg, C. B. et al. Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients. Pain Rep. 3, e651 (2018).
pubmed: 29922743 pmcid: 5999418 doi: 10.1097/PR9.0000000000000651
László, K. et al. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala. Behav. Brain Res. 296, 279–285 (2016).
pubmed: 26386304 doi: 10.1016/j.bbr.2015.09.021
Goodin, B. R., Ness, T. J. & Robbins, M. T. Oxytocin - a multifunctional analgesic for chronic deep tissue pain. Curr. Pharm. Des. 21, 906–913 (2015).
pubmed: 25345612 pmcid: 4276444 doi: 10.2174/1381612820666141027111843
Gravati, M. et al. Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor. J. Neurochem. 114, 1424–1435 (2010).
pubmed: 20557424
Breton, J.-D. et al. Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I–II which amplify GABAergic inhibition. Mol. Pain 4, 19 (2008).
pubmed: 18510735 pmcid: 2430948 doi: 10.1186/1744-8069-4-19
Angulo, M. C., Kozlov, A. S., Charpak, S. & Audinat, E. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J. Neurosci. 24, 6920–6927 (2004).
pubmed: 15295027 pmcid: 6729611 doi: 10.1523/JNEUROSCI.0473-04.2004
Fellin, T. et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43, 729–743 (2004).
pubmed: 15339653 doi: 10.1016/j.neuron.2004.08.011
Corkrum, M. et al. Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity. Neuron 105, 1036–1047.e5 (2020).
pubmed: 31954621 pmcid: 7322729 doi: 10.1016/j.neuron.2019.12.026
Ma, Z., Stork, T., Bergles, D. E. & Freeman, M. R. Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour. Nature 539, 428–432 (2016).
pubmed: 27828941 pmcid: 5161596 doi: 10.1038/nature20145
Pestana, F., Edwards-Faret, G., Belgard, T. G., Martirosyan, A. & Holt, M. G. No longer underappreciated: the emerging concept of astrocyte heterogeneity in neuroscience. Brain Sci. 10, 1–21 (2020).
doi: 10.3390/brainsci10030168
Khakh, B. S. & Deneen, B. The emerging nature of astrocyte diversity. Annu. Rev. Neurosci. 42, 187–207 (2019).
pubmed: 31283899 doi: 10.1146/annurev-neuro-070918-050443
Grinevich, V. & Neumann, I. D. Brain oxytocin: how puzzle stones from animal studies translate into psychiatry. Mol. Psychiatry 26, 265–279 (2021).
Quintana, D. S. et al. Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research. Mol. Psychiatry 26, 80–91 (2021).
Kirsch, P. et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 25, 11489–11493 (2005).
pubmed: 16339042 pmcid: 6725903 doi: 10.1523/JNEUROSCI.3984-05.2005
Takata, N. et al. Optogenetic astrocyte activation evokes BOLD fMRI response with oxygen consumption without neuronal activity modulation. Glia 66, 2013–2023 (2018).
Figley, C. R. & Stroman, P. W. The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur. J. Neurosci. 33, 577–588 (2011).
pubmed: 21314846 doi: 10.1111/j.1460-9568.2010.07584.x
Kastanenka, K. V. et al. A roadmap to integrate astrocytes into systems neuroscience. Glia 68, 5–26 (2019).
Poskanzer, K. E. & Yuste, R. Astrocytes regulate cortical state switching in vivo. Proc. Natl Acad. Sci. USA 2016, 1–10 (2016).
Kjaerby, C., Rasmussen, R., Andersen, M. & Nedergaard, M. Does global astrocytic calcium signaling participate in awake brain state transitions and neuronal circuit function? Neurochem. Res. 42, 1810–1822 (2017).
pubmed: 28210958 pmcid: 5451293 doi: 10.1007/s11064-017-2195-y
Fenoy, A. J., Goetz, L., Chabardès, S. & Xia, Y. Deep brain stimulation: are astrocytes a key driver behind the scene? CNS Neurosci. Ther. 20, 191–201 (2014).
pubmed: 24456263 pmcid: 3969941 doi: 10.1111/cns.12223
Monai, H. & Hirase, H. Astrocytes as a target of transcranial direct current stimulation (tDCS) to treat depression. Neurosci. Res. 126, 15–21 (2018).
pubmed: 29079367 doi: 10.1016/j.neures.2017.08.012
Mills, S. E. E., Nicolson, K. P. & Smith, B. H. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth. 123, e273–e283 (2019).
pubmed: 31079836 pmcid: 6676152 doi: 10.1016/j.bja.2019.03.023
Woo, A. K. Depression and anxiety in pain. Rev. Pain 4, 8–12 (2010).
pubmed: 26527193 pmcid: 4590059 doi: 10.1177/204946371000400103
Oliveira, J. F., Sardinha, V. M., Guerra-Gomes, S., Araque, A. & Sousa, N. Do stars govern our actions? Astrocyte involvement in rodent behavior. Trends Neurosci. 38, 535–549 (2015).
pubmed: 26316036 doi: 10.1016/j.tins.2015.07.006
Rouach, N., Koulakoff, A., Abudara, V., Willecke, K. & Giaume, C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322, 1551–1555 (2008).
pubmed: 19056987 doi: 10.1126/science.1164022
Pannasch, U. et al. Astroglial networks scale synaptic activity and plasticity. Proc. Natl Acad. Sci. USA 108, 8467–8472 (2011).
pubmed: 21536893 pmcid: 3100942 doi: 10.1073/pnas.1016650108
Theis, M. et al. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J. Neurosci. 23, 766–776 (2003).
pubmed: 12574405 pmcid: 6741919 doi: 10.1523/JNEUROSCI.23-03-00766.2003
Teubner, B. et al. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum. Mol. Genet. 12, 13–21 (2003).
pubmed: 12490528 doi: 10.1093/hmg/ddg001
Shigetomi, E. et al. Imaging calcium microdomains within entire astrocyte territories and endfeet with GCaMPs expressed using adeno-associated viruses. J. Gen. Physiol. 141, 633–647 (2013).
pubmed: 23589582 pmcid: 3639581 doi: 10.1085/jgp.201210949
Ting, J. T. et al. Preparation of acute brain slices using an optimized N-methyl-D-glucamine protective recovery method. J. Vis. Exp. (132), 53825 (2018).
Serrano, A., Haddjeri, N., Lacaille, J., Robitaille, R. & Centre-ville, S. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci. 26, 5370–5382 (2006).
pubmed: 16707789 pmcid: 6675310 doi: 10.1523/JNEUROSCI.5255-05.2006
Jourdain, P. et al. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 10, 331–339 (2007).
pubmed: 17310248 doi: 10.1038/nn1849
Ikegaya, Y., Le Bon-Jego, M. & Yuste, R. Large-scale imaging of cortical network activity with calcium indicators. Neurosci. Res. 52, 132–138 (2005).
pubmed: 15893573 doi: 10.1016/j.neures.2005.02.004
Shigetomi, E., Bowser, D. N., Sofroniew, M. V. & Khakh, B. S. Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. J. Neurosci. 28, 6659–6663 (2008).
pubmed: 18579739 pmcid: 2866443 doi: 10.1523/JNEUROSCI.1717-08.2008
Anlauf, E. & Derouiche, A. Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization. Front. Endocrinol. 4, 144 (2013).
doi: 10.3389/fendo.2013.00144
Luis-Delgado, O. E. et al. Calibrated forceps: a sensitive and reliable tool for pain and analgesia studies. J. Pain 7, 32–39 (2006).
pubmed: 16414552 doi: 10.1016/j.jpain.2005.07.011
Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322–328 (2007).
pubmed: 17406592 pmcid: 3623971 doi: 10.1038/nprot.2007.44
King, T. et al. Unmasking the tonic-aversive state in neuropathic pain. Nat. Neurosci. 12, 1364–1366 (2009).
pubmed: 19783992 pmcid: 3427725 doi: 10.1038/nn.2407
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
pubmed: 32015543 pmcid: 7056644 doi: 10.1038/s41592-019-0686-2
Zeisel, A. et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347, 1138–1142 (2015).
pubmed: 25700174 doi: 10.1126/science.aaa1934
Batiuk, M. Y. et al. Identification of region-specific astrocyte subtypes at single cell resolution. Nat. Commun. 11, 1220 (2020).
pubmed: 32139688 pmcid: 7058027 doi: 10.1038/s41467-019-14198-8
Kofuji, P. & Araque, A. G-protein-coupled receptors in astrocyte–neuron communication. Neuroscience https://doi.org/10.1016/j.neuroscience.2020.03.025 (2020).
Octeau, J. C. et al. Transient, consequential increases in extracellular potassium ions accompany channelrhodopsin2 excitation. Cell Rep. 27, 2249–2261 (2019).
pubmed: 31116972 pmcid: 6582980 doi: 10.1016/j.celrep.2019.04.078
Reeves, A. M. B., Shigetomi, E. & Khakh, B. S. Bulk loading of calcium indicator dyes to study astrocyte physiology: key limitations and improvements using morphological maps. J. Neurosci. 31, 9353–9358 (2011).
pubmed: 21697385 pmcid: 3142876 doi: 10.1523/JNEUROSCI.0127-11.2011

Auteurs

Jérôme Wahis (J)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.
KU Leuven, Leuven Brain Institue, Department of Neurosciences, VIB-KU Leuven Center for Brain and Disease Research, Laboratory of Glia Biology, Leuven, Belgium.

Angel Baudon (A)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Ferdinand Althammer (F)

Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta GA, USA.

Damien Kerspern (D)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Stéphanie Goyon (S)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Daisuke Hagiwara (D)

Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Arthur Lefevre (A)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.
Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Lara Barteczko (L)

Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Benjamin Boury-Jamot (B)

Center for Psychiatric Neurosciences, Hôpital de Cery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Benjamin Bellanger (B)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Marios Abatis (M)

Center for Psychiatric Neurosciences, Hôpital de Cery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Miriam Da Silva Gouveia (M)

German Cancer Research Center (DKFZ), Heidelberg, Germany.

Diego Benusiglio (D)

Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Marina Eliava (M)

Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Andrei Rozov (A)

OpenLab of Neurobiology, Kazan Federal University, Kazan, Russia, Federal Center of Brain Research and Neurotechnologies, Moscow, Russia and Department of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany.

Ivan Weinsanto (I)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Hanna Sophie Knobloch-Bollmann (HS)

Department of Molecular and Cellular Biology, Center for Brain Science, Harvard University, Cambridge MA, USA.
Group of Systemic and Cellular Neuroscience, Institute of Physiology, University of Freiburg, Freiburg, Germany.

Matthew K Kirchner (MK)

Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta GA, USA.

Ranjan K Roy (RK)

Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta GA, USA.

Hong Wang (H)

Department of Pharmacology, Heidelberg University, Heidelberg, Germany.
The Brain Cognition and Brain Disease Institute of Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Beijing, China.

Marie Pertin (M)

Pain center, Department of Anesthesiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Perrine Inquimbert (P)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Claudia Pitzer (C)

Interdisciplinary Neurobehavioral Core (INBC), Ruprecht-Karls-Universität, Heidelberg, Germany.

Jan Siemens (J)

Department of Pharmacology, Heidelberg University, Heidelberg, Germany.

Yannick Goumon (Y)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Benjamin Boutrel (B)

Center for Psychiatric Neurosciences, Hôpital de Cery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Christophe Maurice Lamy (CM)

Division of Anatomy, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Isabelle Decosterd (I)

Pain center, Department of Anesthesiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Department of Fundamental Neurosciences, Faculty of Biology and Medicine (FBM), University of Lausanne, Lausanne, Switzerland.

Jean-Yves Chatton (JY)

Pain center, Department of Anesthesiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Nathalie Rouach (N)

Neuroglial Interactions in Cerebral Physiopathology, Center for Interdisciplinary Research in Biology, Collège de France, Centre National de la Recherche Scientifique UMR 7241, Institut National de la Santé et de la Recherche Médicale U1050, Labex Memolife, PSL Research University, Paris, France.

W Scott Young (WS)

Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Javier E Stern (JE)

Center for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta GA, USA.

Pierrick Poisbeau (P)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Ron Stoop (R)

Center for Psychiatric Neurosciences, Hôpital de Cery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Pascal Darbon (P)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France.

Valery Grinevich (V)

Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany. valery.grinevich@zi-mannheim.de.

Alexandre Charlet (A)

Centre National de la Recherche Scientifique, University of Strasbourg, Institute of Cellular and Integrative Neurosciences, Strasbourg, France. acharlet@unistra.fr.
University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France. acharlet@unistra.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH